Development and Validation of an HPLC Method for Determination of Antidiabetic Drug Alogliptin Benzoate in Bulk and Tablets

Alogliptin benzoate, a member of dipeptidyl peptidase-4 inhibitors, is a recent drug developed by Takeda Pharmaceutical Company for the treatment of Type 2 diabetes; it potentiates the effect of incretin hormones through the inhibition of their degradation. Alogliptin can be used alone or in combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseef, Hani, Moqadi, Ramzi, Qurt, Moammal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174800/
https://www.ncbi.nlm.nih.gov/pubmed/30345140
http://dx.doi.org/10.1155/2018/1902510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174800/
https://www.ncbi.nlm.nih.gov/pubmed/30345140
http://dx.doi.org/10.1155/2018/1902510

Ejemplares similares